The intraaortic balloon pump (IABP) has been employed in the management of five patients with ventricular septal rupture (VSD) and six patients with acute mitral regurgitation (AMR) following myocardial infarction. All patients were in cardiogenic shock which responded poorly to medical therapy including pressor and inotropic agents. IABP resulted in significant clinical and hemodynamic improvement in all cases.
dial infarction may lead to rapid clinical deterioration with pulmonary edema, hypotension, and a high early mortality.'-3 Pressor agents which increase afterload can aggravate mitral regurgitation and will increase left-to-right shunting. Ino- the possible cost of increased myocardial ischemia. 4 In contrast, counterpulsation can decrease ischemia by raising coronary perfusion pressure and will reduce afterload. [5] [6] [7] [8] [9] [10] [11] [12] This report summarizes our experience in attempting to stabilize critically ill patients with these mechanical complications utilizing the intraaortic balloon pump (IABP).
Material and Methods
Hemodynamic studies were performed in 11 patients admitted to the Myocardial Infarction Research Unit Intensive Study Area. In all patients, acute myocardial infarction was documented by a typical history, diagnostic electrocardiographic changes, and serum enzyme studies. Five patients had ventricular septal defect (VSD) [1] [2] [3] [4] [5] [6] [7] [8] [9] days after acute infarction. In two cases the infarction was anterior and in three inferior. Six patients developed acute mitral regurgitation (AMR) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] days after infarction. In three patients the infarction was anterior and in three inferior (table 1) .
At the time of study all patients with VSD showed vasoconstriction, systemic hypotension, and low central venous oxygen saturation. Patients with AMR all GOLG ET AL. green injected into the pulmonary artery and sampled from the radial artery. In all patients an IABP "on-off" study was performed daily. Systemic and pulmonary artery pressures, PCW pressure, and electrocardiogram were recorded followed by duplicate determinations of cardiac output and oxygen saturation. IABP was then interrupted; 3-10 min were allowed to elapse during which pressures were monitored continuously. Before resuming IABP, cardiac output and oxygen saturation determinations were repeated. IABP was then resumed and after 5 min a third set of measurements were taken.
In three patients (two VSD, one AMR) angiotensin was then infused in low dose (1.25 p,g/min) during continuous IABP to abolish the effect of IABP on afterload. When systolic arterial pressure had been matched to the level prior to the institution of pumping, a fourth set of measurements was obtained. 
Results
In the patients with VSD, the mean PCW pressure fell from 17 to 13 mm Hg (P < 0.01). There was a small but significant rise in mean arterial pressure without a significant change in Figure 4 The hemodynamic response to IABP in six patients with acute mitral regurgi-tation. During IABP there is a significant fall in wedge pressure and a small but significant rise in cardiac output (CO). MAP = mean arterial pressure; HR = heart rate.
Circulation, Volume XLVII, June 1973 heart rate ( fig. 1 ). Systemic A-V 02 difference fell from an average of 9.7 + 2.4 (SD) to 8.1 + 2.4 vol % (P < 0.05) while pulmonary A-V 02 difference remained low and unchanged. Thus the mean P/S flow ration fell from 5.1/1 to 4.2/1 (P <0.05) secondary to a selective increase in systemic output ( fig. 2) .
The effect on the intracardiac shunt was produced by a reduction in left ventricular afterload. When angiotensin was infused during IABP and systolic arterial pressure was matched to the level present prior to the institution of balloon pumping, the P/S flow ratio returned to prepumping levels in spite of a marked increase in coronary perfusion pressure ( fig. 3) .
In the patients with AMR, the mean PCW pressure fell from 25 to 20 mm Hg (P < 0.02) with initiation of IABP. Mean arterial pressure remained unchanged while the heart rate fell from 99 to 95 beats/min (P <0.02). This was associated with an average rise in cardiac output from 3.1 to 3.7 liters/min (P <0.01, fig. 4 ). Interruption of IABP was accompanied by a rise in PCW pressure and an increase in the amplitude of the systolic regurgitant 'Y' waves ( fig. 5 ). Angiotensin was infused at 1.25 gg/min during IABP in one patient, and cardiac output, PCW pressure, and regurgitant "V" waves all returned to prepumping levels.
All patients in both groups improved hemodynamically and showed maximum stabilization by 24 hours. Nevertheless, at this point all continued to show balloon dependence13 with inadequate circulatory dynamics during test interruption of IABP. Two patients with VSD and three with AMP. were continued on IABP for a longer period prior to angiography. All showed hemodynamic deterioration despite continued circulatory assistance.
The angiograms revealed extensive coronary disease in both groups. All patients with VSD showed high-grade proximal left anterior descending coronary obstruction. Five The effect of IABP on acute mitral regurgitation. At the arrow the balloon pump is turned off. 
